Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls

被引:390
作者
Pocock, SJ
Clayton, TC
Altman, DG
机构
[1] Univ London London Sch Hyg & Trop Med, Med Stat Unit, London WC1E 7HT, England
[2] Ctr Stat Med, Oxford, England
关键词
D O I
10.1016/S0140-6736(02)08594-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Survival plots of time-to-event data are a key component for reporting results of many clinical trials (and cohort studies). However, mistakes and distortions often arise in the display and Interpretation of survival plots. This article aims to highlight such pitfalls and provide recommendations for future practice. Findings are illustrated by topical examples and also based on a survey of recent clinical trial publications In four major journals. Specific issues are: should plots go up or down (we recommend up), how far in time to extend the plot, showing the extent of follow-up, displaying statistical uncertainty by including SEs or CIS, and exercising caution when Interpreting the shape of plots and the time-pattern of treatment difference.
引用
收藏
页码:1686 / 1689
页数:4
相关论文
共 16 条
[1]   Calculating the number needed to treat for trials where the outcome is time to an event [J].
Altman, DG ;
Andersen, PK .
BRITISH MEDICAL JOURNAL, 1999, 319 (7223) :1492-1495
[2]   REVIEW OF SURVIVAL ANALYSES PUBLISHED IN CANCER JOURNALS [J].
ALTMAN, DG ;
DESTAVOLA, BL ;
LOVE, SB ;
STEPNIEWSKA, KA .
BRITISH JOURNAL OF CANCER, 1995, 72 (02) :511-518
[3]  
Altman DG, 1991, PRACTICAL STAT MED R
[4]  
ALTMAN DG, 2000, STAT CONFIDENCE, pCH9
[5]  
Boutitie F, 1998, STAT MED, V17, P2883, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2883::AID-SIM900>3.0.CO
[6]  
2-L
[7]  
Chamberlain DA, 1997, LANCET, V350, P461
[8]  
Collett D, 2014, MODELLING SURVIVAL D
[9]  
Hall A, 2000, LANCET, V356, P851, DOI 10.1016/S0140-6736(00)02667-2
[10]   NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481